NA Genetic Testing Market - Industry Trends and Forecast to 2029

Segmentation

Short Description
North America Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New Born Screening, Predictive And Presymptomatic Testing, Other Types), Technology (DNA sequencing, Polymerase Chain Reaction, Microarrays, Whole Genome Sequencing, Fluorescence In Situ Hybridization (FISH), Others), Diseases (Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntingtons Disease, Fragile X Syndrome, Other Diseases) End User (Hospitals, Clinics, Diagnostic Centers, Private Clinics, Laboratory Service Providers, Private Laboratories)
Industry Trends and Forecast to 2029.

Market Definition:

Genetic testing is a kind of medical test that identifies changes in genes, chromosomes, or proteins. The outcome of a genetic test can confirm or rule out a suspected genetic condition or aid in determining a persons chance of developing or passing on a genetic disorder. Over 77,000 genetic tests are currently in use, and others are being developed.
The increasing innovations and technologies and rising number of players in the market, and novel product launches are also propelling the growth of the global genetic testing market.
Market Segmentation:
North America genetic testing market is categorized into four notable segments which are based on type, technology, diseases and end user.  In 2022, diagnostic testing segment is expected to dominate the market due to technological advancement in the genetic testing.
 On the basis of type, the North America genetic testing market is segmented into carrier testing, diagnostic testing, new born screening, predictive and presymptomatic testing, other types. 
 On the basis of technology, the North America genetic testing market is segmented into DNA sequencing, polymerase chain reaction, microarrays, whole genome sequencing, fluorescence in situ hybridization (FISH), others.
 On the basis of technology, the North America genetic testing market is segmented into DNA sequencing, polymerase chain reaction, microarrays, whole genome sequencing, fluorescence in situ hybridization (FISH), others.
 On the basis of end user, the North America genetic testing market is segmented hospitals, clinics, diagnostic centers, private clinics, laboratory service providers, private laboratories.

Market Players

The key market players for the North America genetic testing market are listed below:
 Thermo Fisher Scientific Inc.
 Invitae Corporation
 Bio-Rad Laboratories, Inc.
 PerkinElmer Inc.
 Illumina, Inc.
 QIAGEN
 F. Hoffmann-La Roche Ltd.
 Fulgent Genetics
 Myriad Genetics, Inc.
 Abbott
 Eurofins Scientific
 Sorenson Genomics
 Biocartis
 Cepheid ( A subsidiary of Danaher)
 PacBio
 Otogenetics
 BioReference
 Sema4 OpCo, Inc.
 Natera, Inc.

Methodology